Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Sep 26, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹38.309-1.7% 1 day change | 21.64% p.a. | App exclusive | ₹2,961 Cr |
AUM (Fund size) | ₹2,961 Cr |
Exit load | 0.5% Exit load of 0.50% if redeemed within 1 month.! |
Lock-in Period | Nil |
Age | 6 yrs 10 m since Nov 12, 2018 |
Benchmark | BSE Healthcare TRI |
Min. investment | This scheme is currently not buyable |
Expense ratio | 1.93% as on Aug 31, 2025 |
Plan type | Regular |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | -1.82% | -1.58% |
3 Months | -1.79% | -2.06% |
6 Months | 2.44% | 4.18% |
1 Year | -6.15% | -2.96% |
2 Years | 20.83% | 21.59% |
3 Years | 22.13% | 22.12% |
4 Years | 13.22% | 13.29% |
5 Years | 16.86% | 16.81% |
Large Cap 25.75%
Mid Cap 19.58%
Small Cap 54.27%
Other Cap 0%
Healthcare 97.52%
Insurance 1.53%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Foreign - Equity 12.71%
Reverse Repo 0.6%
Foreign Mutual Funds 0.55%
Others 0.6%
Global X Genomics & Biotechnology ETF 0.55%
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
DSP Healthcare Fund | -1.82% | 2.44% | -6.15% | 22.13% | 16.86% | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -1.59% | 7.82% | 0.05% | 26.79% | 19.52% | 14.7% |
SBI Healthcare Opportunities Fund | -1.82% | 2.09% | 0.02% | 24.46% | 18.75% | 10.81% |
Tata India Pharma & Healthcare Fund | -1.38% | 4.72% | -3.75% | 21.66% | 17.13% | 11.57% |
Mirae Asset Healthcare Fund | -0.99% | 3.4% | -3.37% | 19.92% | 16.8% | 14.21% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
DSP Healthcare Fund | 14.57 | 0.84 | 1.14 | 1.87 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.51 | 0.94 | 1.27 | 1.79 |
SBI Healthcare Opportunities Fund | 13.91 | 0.84 | 1.29 | 1.93 |
Tata India Pharma & Healthcare Fund | 15.94 | 0.97 | 1.0 | 1.54 |
Mirae Asset Healthcare Fund | 16.36 | 1.0 | 0.86 | 1.36 |
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 10 m | 1.93% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,162 Cr | 7 yrs 3 m | 1.88% |
SBI Healthcare Opportunities Fund | N.A. | 3,963 Cr | 26 yrs 3 m | 1.93% |
Tata India Pharma & Healthcare Fund | N.A. | 1,232 Cr | 9 yrs 9 m | 2.1% |
Mirae Asset Healthcare Fund | N.A. | 2,796 Cr | 7 yrs 3 m | 1.93% |
Alpha | 2.32 vs. 5.81 Underperformed at beating benchmark |
Sharpe | 1.14 vs. 3.71 Poor risk-adjusted returns |
Beta | 0.84 vs. 0.71 More sensitive to market's ups & downs |
Standard deviation | 14.57 vs. 9.06 More volatile performance |
Fund AUM | 2,961 Cr as on May 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
No. of schemes | 54 view all schemes |
Total AUM | 1,98,256 Cr as on Jun 30, 2025 |
Address | NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai, 400069 |
Phone | 1800-208-4499 / 1800-200-4499 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
DSP India T.I.G.E.R. Fund | N.A. | 5,319 Cr | -11.07% | 33.19% |
DSP Natural Resources and New Energy Fund | N.A. | 1,292 Cr | -7.03% | 26.93% |
DSP Small Cap Fund | N.A. | 16,305 Cr | -5.6% | 26.23% |
DSP ELSS Tax Saver Fund | N.A. | 16,974 Cr | -5.29% | 23.36% |
DSP Nifty 50 Equal Weight Index Fund | N.A. | 2,136 Cr | -5.29% | 22.71% |
DSP Large & Mid Cap Fund | N.A. | 15,013 Cr | -5.85% | 22.67% |
The current Net Asset Value (NAV) of the DSP Healthcare Fund plan is approximately ₹38.309 as of Sep 26, 2025.
The DSP Healthcare Fund is a 6 yrs 10 m old fund and has delivered average annual returns of 21.64% since inception.
1-Year | 3-Year | 5-Year | Since Inception |
---|---|---|---|
-6.15% | 22.13% | 16.86% | 21.64% |
The DSP Healthcare Fund has an expense ratio of 1.93%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The DSP Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 2,961 Cr as on May 31, 2025.
The DSP Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Cipla Ltd. | 8.86% |
Cohance Lifesciences Ltd. | 8.81% |
Sun Pharmaceutical Industries Ltd. | 8.7% |
Ipca Laboratories Ltd. | 8.16% |
Gland Pharma Ltd. | 4.94% |
Alembic Pharmaceuticals Ltd. | 4.91% |
Globus Medical Inc | 4.59% |
Laurus Labs Ltd. | 4.57% |
Apollo Hospitals Enterprise Ltd. | 4.53% |
Sai Life Sciences Ltd. | 4.08% |
The DSP Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 97.52% |
Insurance | 1.53% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the DSP Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.